Dr. Cerniglia is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1441 Eastlake Ave
Los Angeles, CA 90033
Education & Training
- University of Southern California/Los Angeles General Medical Center (USC/LA General)Fellowship, Hematology and Medical Oncology, 2023 - 2026
- Saint Joseph HospitalResidency, Internal Medicine, 2019 - 2022
- Georgetown University School of MedicineClass of 2019
Certifications & Licensure
- CA State Medical License 2023 - 2025
- CO State Medical License 2021 - 2025
Publications & Presentations
PubMed
- 1 citationsResponse to PD-1 inhibitor after progression on PD-L1 inhibitor in advanced HCC.Michael Cerniglia, Michal Klepadlo, David Sheneman, Sunnie S Kim
BMJ Case Reports. 2022-08-12 - 2 citationsTreatment of Metastatic Disease with Immune Checkpoint Inhibitors Nivolumab and Pembrolizumab: Effect of Performance Status on Clinical Outcomes.Leah Wells, Michael Cerniglia, Sarah Hall, Audrey C Jost, Gregory Britt
Journal of Immunotherapy and Precision Oncology. 2022-05-01 - 3 citationsAssociation of Homologous Recombination-DNA Damage Response Gene Mutations with Immune Biomarkers in Gastroesophageal Cancers.Michael Cerniglia, Joanne Xiu, Axel Grothey, Michael J. Pishvaian, Yasmine Baca
Molecular Cancer Therapeutics. 2021-11-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: